Mitochondrial Protein Synthesis and Degradation: MTRF1 as A Drug Target Or Biomarker

Target Name: MTRF1

NCBI ID: G9617

MTRF1

Mitochondrial Protein Synthesis and Degradation: MTRF1 as A Drug Target Or Biomarker

Mitochontrial peptide chain release factor 1 (MTRF1) is a protein that is expressed in the mitochondria, which are organelles responsible for generating energy in the cell through a process called cellular respiration. MTRF1 is involved in the regulation of mitochondrial protein synthesis and degradation, which is critical for the function of the mitochondria.

Recent studies have suggested that MTRF1 may be a drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. This is because MTRF1 is involved in a wide range of cellular processes that are important for the health and function of cells, and disruptions in these processes can lead to the development of disease.

One potential mechanism by which MTRF1 may be involved in the development of cancer is by regulating the expression of genes that are involved in cell growth and division. MTRF1 has been shown to play a role in the regulation of the expression of genes that are important for the development and progression of cancer. For example, studies have shown that MTRF1 can inhibit the expression of genes that are involved in the development of breast cancer, and that this inhibition may be a potential therapeutic approach for breast cancer treatment.

Another potential mechanism by which MTRF1 may be involved in the development of neurodegenerative diseases is by regulating the expression of genes that are involved in the maintenance of brain cells. MTRF1 has been shown to play a role in the regulation of the expression of genes that are important for the survival and maintenance of brain cells, and disruptions in these processes have been implicated in the development of neurodegenerative diseases. For example, studies have shown that MTRF1 can

Protein Name: Mitochondrial Translation Release Factor 1

Functions: Mitochondrial peptide chain release factor that directs the termination of translation in response to the peptide chain non-cognate termination stop codons AGG and AGA

The "MTRF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets